Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Myocardial Ischemia peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Myocardial Ischemia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
2 profiles.
2024–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 60 selected PubMed records and 29 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Myocardial Ischemia unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00089895
PeptideScanner retained ClinicalTrials.gov record NCT00089895 at 2026-11-15T21:59:29.646Z. Its registry update date was 2024-05-17, and PeptideScanner's reviewed identity mapping was eptifibatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 17, 2024
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03537586
PeptideScanner retained ClinicalTrials.gov record NCT03537586 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 4, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Bivalirudin · 2026-11-04
ClinicalTrials.gov record NCT03537586
Active, not recruiting at the retained observation.
Open attributed record →Eptifibatide · 2024-05-17
ClinicalTrials.gov record NCT00089895
Completed at the retained observation.
Open attributed record →